# Tirofiban for Reduction of Thromboembolic Events in Endovascular Unruptured Aneurysm Repair

> **NCT06238115** · PHASE2,PHASE3 · COMPLETED · sponsor: **Beijing Tiantan Hospital** · enrollment: 192 (actual)

## Conditions studied

- Unruptured Intracranial Aneurysm
- Flow Diverter
- Stent-assisted Coiling
- Thromboembolic Events

## Interventions

- **DRUG:** Tirofiban
- **DRUG:** aspirin, clopidogrel

## Key facts

- **NCT ID:** NCT06238115
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-04
- **Primary completion:** 2025-10-09
- **Final completion:** 2025-11-09
- **Target enrollment:** 192 (ACTUAL)
- **Last updated:** 2025-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06238115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06238115, "Tirofiban for Reduction of Thromboembolic Events in Endovascular Unruptured Aneurysm Repair". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06238115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*